Rezolute (RZLT) Leases (2019 - 2026)

Rezolute recorded quarterly Leases of $918000.0 in Q1 2026, down 13.72% quarter-over-quarter from $1.1 million in Q4 2025, and down 38.18% year-over-year from $1.5 million in Q1 2025.

Rezolute's Leases history runs 8 years deep, the most recent figure standing at $918000.0 for Q1 2026.

  • In Q1 2026, Leases fell 38.18% year-over-year to $918000.0; the TTM figure through Mar 2026 stood at $918000.0 (down 38.18% YoY), while the FY2025 annual figure was $1.3 million, down 28.3% from the prior year.
  • Leases came in at $918000.0 for Q1 2026 at Rezolute, down from $1.1 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $2.3 million in Q4 2022 to a low of $130000.0 in Q3 2022.
  • A 5-year average of $1.4 million and a median of $1.6 million in 2024 frame the typical range for Leases.
  • Across the five-year window, Leases plunged 62.92% in 2022 and surged 1386.92% in 2023, its largest moves.
  • Rezolute's Leases stood at $2.3 million in 2022, then fell by 7.15% to $2.1 million in 2023, then retreated by 23.99% to $1.6 million in 2024, then plunged by 34.28% to $1.1 million in 2025, then declined by 13.72% to $918000.0 in 2026.
  • According to Business Quant data, Leases over the past three periods registered $918000.0, $1.1 million, and $1.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Leases (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 83,048.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 61,822.50
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 285.20 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1.69 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 189.30 Mn
10 Rezolute 374.41 Mn 374.41 Mn - 918,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 918,000.00
Dec 31, 2025 1.06 Mn
Sep 30, 2025 1.21 Mn
Jun 30, 2025 1.35 Mn
Mar 31, 2025 1.49 Mn
Dec 31, 2024 1.62 Mn
Sep 30, 2024 1.75 Mn
Jun 30, 2024 1.88 Mn
Mar 31, 2024 2.01 Mn
Dec 31, 2023 2.13 Mn
Sep 30, 2023 1.93 Mn
Jun 30, 2023 2.05 Mn
Mar 31, 2023 2.17 Mn
Dec 31, 2022 2.29 Mn
Sep 30, 2022 130,000.00
Jun 30, 2022 152,000.00
Mar 31, 2022 175,000.00
Dec 31, 2021 237,000.00
Sep 30, 2021 317,000.00
Jun 30, 2021 396,000.00
Mar 31, 2021 472,000.00
Dec 31, 2020 547,000.00
Sep 30, 2020 325,000.00
Jun 30, 2020 383,000.00
Mar 31, 2020 441,000.00
Dec 31, 2019 497,000.00
Sep 30, 2019 552,000.00